Cognizant filed Q1 2026 10-Q on April 29 alongside Project Leap, a $230-320M restructuring program. Headline revenue grew 5.8% USD / 3.9% CC. Stock down 22% from the Q1 buyback average of $68.23. The income statement reads ordinary. The MD&A footnote attributions tell a different story.

What the filing says

Strip 3Cloud's acquisition contribution (+90 bps to CC growth, disclosed) and third-party product pass-throughs (+140 bps, disclosed) and organic CC growth is approximately 1.6% on $22B annualized revenue.

Segment math is sharper. CMT reported +6.5% CC, but TP products contributed 1,000 basis points — organic CMT is approximately -3.5%. MD&A is explicit: "weakness among communications and media customers... may continue, partially offset by growth in technology customers."

Health Sciences runs the other way. The -0.9% CC headline reads bearish, but TP products dragged HS by 300 bps and underlying services grew ~+2.1% CC with segment margin improving 160 bps. The bear consensus that leans on HS deterioration as a thesis leg is wrong.

Project Leap: zero Q1 charges. All $230-320M ($200-270M severance) lands Q2+. Net 2026 P&L impact at midpoints ~-$25M. Third consecutive restructuring (NextGen 2023, 2024 actions, now Leap).

Zero AI revenue disclosure. Two acquisitions — 3Cloud ($733M, closed Jan 1) and Astreya Partners ($600M, announced Apr 25) — represent buying AI capability rather than building it.

What the market thinks

CTSH at 11.5x forward P/E (sector low), RSI 32.3, IV rank 81%. OTM put skew is +23.5% — the left tail is richly priced, expensive to express via puts. EXLS RSI 69.5, 19.9x forward, 59.9% AI-led revenue disclosed. The broad "AI displacement of services" narrative is consensus. RSI asymmetry between the two means any pair structure today buys strength and shorts weakness — entry timing is suboptimal.

Why the gap exists

The disaggregation insight isn't priced. ACN reported Q2 FY26 CMT growth of +10% CC — looks healthy. But ACN commingles Communications, Media, and Technology in one segment. Peers that disaggregate all show comms/media weakness: TCS Communication & Media -2.1% CC Q4 FY26 (worst-performing TCS vertical), HCLTech "two large US Telecom clients reduced discretionary spending," CTSH organic CMT -3.5%.

The IT services bifurcation isn't AI-winners-vs-losers. It's Tech-customer-shielded versus comms/media-exposed. Most analysts read ACN's commingled +10% as evidence the sector is fine. Pure comms/media is in secular decline; it surfaces only when peers break it out.

The TP product accounting mask is the second piece. The math is in MD&A footnotes but missed by tape reacting to headline +3.9%.

Risks (ranked)

  1. CTSH M&A — 11.5x P/E with $1.5B buyback authorization invites a defensive PE / strategic bid. ≈5% probability would wipe ≈15% of pair return.
  2. Sector squeeze on Fed pivot or AI-fear cooling — extreme positioning means 8-12% bounces are easy.
  3. EXLS Q2 disappointment — long leg fragile if AI-led decelerates below 22%.
  4. ACN begins disaggregating CMT — compresses factor edge from ≈70% to ≈30%.
  5. Size factor residual — EXLS $5-7B vs CTSH $39B; small-cap rotation hurts the pair regardless of thesis.

Catalysts

  • June 25 — ACN Q3 FY26: first decision point for the factor edge
  • July 9 — TCS Q1 FY27 Communication & Media trajectory
  • July 17 — INFY Q1 FY27 Communication vertical
  • July 24-30 — CTSH Q2 and EXLS Q2 back-to-back

The cluster does most of the work. Everything before late June is positioning.

What would change our mind

  • ACN Q3 FY26 CMT organic ≥ 5%: factor edge holds
  • ACN Q3 FY26 CMT organic < 5%: factor moving to consensus, edge compresses
  • CTSH Q2 organic CMT ≥ 0%: bear thesis on CMT structurally cracks
  • EXLS Q2 AI-led growth holds 27%+: capability gap confirmed
  • CTSH M&A speculation: pair exits

Evidence

EvidenceSourceCredibilityLR
Q1 organic CC ≈1.6% after stripping 3Cloud (+90bps) and TP products (+140bps)10-Q 2026-04-29, MD&A0.900.65
CMT organic ~-3.5%; "weakness among comms/media customers... may continue"10-Q 2026-04-29, MD&A segment0.950.80
HS underlying services +2.1% CC; segment margin +160bps10-Q 2026-04-29, segment0.951.15
Project Leap: zero Q1 charges, all $230-320M Q2+; 3rd consecutive restructuring10-Q 2026-04-29, subsequent events0.950.70
Zero AI revenue disclosure (vs EXLS 59.9%)10-Q 2026-04-29, MD&A0.950.65
Cross-ticker: TCS C&M -2.1% Q4 FY26, HCLTech US telecom client weaknessTCS Q4 FY26 PR, HCLTech IR0.921.4
ACN Q2 FY26 CMT (Tech-commingled) +10% CCACN Q2 FY26 release0.951.0 (masking, not disconfirming)
Gross margin -80 bps despite FX tailwind; hedge book $93M queued for next 12mo10-Q 2026-04-29, derivatives0.950.75
OCF -31.5% YoY; Astreya $600M close pending10-Q 2026-04-29, cash flow0.950.80

Pair EV (EXLS vs CTSH, dollar-balanced) is approximately +8-10% over six months at Sharpe ≈0.5. Outright CTSH fails the 75%+ idio variance test (≈15-25% idio, ≈75-85% factor). The strongest edge is structural disaggregation, not narrative.